• 企業・知財を促進
    • スタートアップ企業一覧
    • IP&技術一覧
  • ヘルプを取得
    • 質問を検索
    • プロジェクトを投稿
    • 専門家Directoryを検索
  • リソース
    • ドキュメントセンター
    • 特許を検索
    • 専門家の記事・ブログ
  • ニュース
    • Tech&IPニュース
  • マイアカウント
  • ログイン
  • 専門家向け

特許

68,026 件
全IP種別
PATENTFIELDで検索
IPを掲載
権利維持

Polypeptide immobilization

Polypeptide immobilization

係属中

Microfluidics

Microfluidics is a multidisciplinary field intersecting engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, with practical applications to the design of systems in whi...

権利維持

Microbe-mediated epithelial...

Microbe-mediated epithelial disorders

権利維持

Ferromagnetic materials

The table on the right lists a selection of ferromagnetic and ferrimagnetic compounds, along with the temperature above which they cease to exhibit spontaneous magnetization (see Curie temperature)...

係属中

Protein A

Protein A is a 42 kDa surface protein originally found in the cell wall of the bacterium Staphylococcus aureus. It is encoded by the spa gene and its regulation is controlled by DNA topology, cellu...

係属中

Inhibiting farnesoid X rece...

The bile acid receptor (BAR), also known as farnesoid X receptor (FXR) or NR1H4 (nuclear receptor subfamily 1, group H, member 4) is a nuclear receptor that is encoded by the NR1H4 gene in humans. ...

係属中

Plant centromere

The centromere is the part of a chromosome that links sister chromatids. During mitosis, spindle fibers attach to the centromere via the kinetochore.[1] Centromeres were first defined as genetic lo...

係属中

Therapeutic delivery

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect.[1] It ...

係属中

Staphylococcal infection

Staphylococci are species of Gram-positive bacteria that can cause a wide variety of infections in humans and other animals through infection or the production of toxins. Staphylococcal toxins are ...

権利維持

Treatment of inflammatory d...

Treatment of inflammatory diseases

係属中

Platelet aggregation inhibi...

An antiplatelet drug (antiaggregant) is a member of a class of pharmaceuticals that decrease platelet aggregation [1] and inhibit thrombus formation. They are effective in the arterial circulation,...

係属中

Molecular cartesian-coordin...

Molecular cartesian-coordinate platforms

係属中

5-Methylcytosine

5-Methylcytosine is a methylated form of the DNA base cytosine that may be involved in the regulation of gene transcription. When cytosine is methylated, the DNA maintains the same sequence, but th...

係属中

Demyelinating disorder

A demyelinating disease is any disease of the nervous system in which the myelin sheath of neurons is damaged.[1] This damage impairs the conduction of signals in the affected nerves. In turn, the ...

係属中

Constipation in opiod users

Constipation develops in many people on opioids because opioids directly inhibit and disrupt normal functions of the intestinal tract. Since tolerance to this problem does not develop readily, most...

係属中

Fibrils

Fibril is a fine fiber, such as a myofibril or neurofibril.[1] Neurofilaments are about 10 nanometers in diameter. Cytoplasmic fibrils are observed on the protoplasmic cylinders found in most sp...

係属中

Closed loop workflow

Closed loop workflow

権利維持

Fatty acid-binding proteins

The fatty-acid-binding proteins (FABPs) are a family of transport proteins for fatty acids and other lipophilic substances such as eicosanoids and retinoids.[1][2] These proteins are thought to fac...

係属中

Cancer vaccine

A cancer vaccine is a vaccine that treats existing cancer or prevents the development of cancer in certain high-risk individuals. Vaccines that treat existing cancer are known as therapeutic cancer...

権利維持

Leukemia

Leukemia (American English) or leukaemia (British English) /luːˈkiːmiːə/[1] is a group of cancers that usually begins in the bone marrow and results in high numbers of abnormal white blood cells.[2...

  • 最初
  • 前
  • …
  • 1767
  • 1768
  • 1769
  • 1770
  • 1771
  • 1772
  • 1773
  • 1774
  • 1775
  • …
  • 次
  • 最後
イノベーションと知的財産権のためのone-stop shop 今すぐ参加

IP Nexusについて

IP Nexusは、大学・研究機関と連携して新規技術の潜在的なビジネス価値を解明し、技術シーズ・スタートアップ企業を成功へと導かせ、投資家やその他のステークホルダーに貴重なリターンを生み出す知的財産(IP)の商業化企業です。テクノロジーとライフサイエンスにフォーカスしたハイポテンシャルな発明を早期に特定してコマーシャルディレクション、資金調達の専門知識およびマネジメント能力を提供します。アジア地域に特化した専門知識によりアジア地域にフォーカスしています。

免責事項

IP Nexusは、Ask an ExpertとService Marketplaceを提供しています。Ask an ExpertとService Marketplaceは、インタラクティブなオンラインサービスであり、迅速かつ容易にビジネスのための法的相談や法的サービスを見つけることができます。IP Nexusは、法律事務所ではなく、法的助言、法律家の斡旋などの法的サービスを提供することはなく、自ら法的代理を行うことはありません。

コンテンツ

  • 価格
  • よくある質問
  • 知的財産権(IP)の保護
  • 知的財産権(IP)の種類
  • 知的財産権(IP)に関する申し立て
  • 我々のチームについて
  • スタートアップ
  • お問い合せ
  • ブランド資産
  • 利用規約
  • プライバシーポリシー
  • PATENTFIELDで特許を検索

ニュースレター

購読

言語設定

© 2026 IP Nexus. All Rights Reserved.

レポート内容

      問い合わせフォーム